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Community pharmacies provide the convenience and ease of administrating vaccinations 
outside traditional settings. Vaccinations are health initiatives that protect communities and 
improve health outcomes in all populations. Despite their accessibility and supporting clinical 
data, various influential factors contribute to the current suboptimal rates of vaccine 
administration. Given the common barriers to vaccine administration, this research narrows 
down to address a specific barrier and attempts to implement a method that focuses on improving 
vaccine rates in community pharmacies. This research is a case study that utilizes the DMAIC 
model of lean six sigma and aims to use this quality improvement process to identify, measure, 
analyze, and implement a training program to facilitate pharmacists in high-quality vaccine 
recommendations to promote higher rates of pneumococcal vaccinations in community settings.  
Keywords: pneumococcal vaccine, vaccine hesitancy, lean six sigma, DMAIC, pharmacists, 
Walgreens, quality improvement.  
Abbreviations:  
LSS: Lean Six Sigma 
DMAIC: Define, Measure, Analyze, Implement, Control 
PCV13: pneumococcal conjugate vaccine 
PPSV23: pneumococcal polysaccharide vaccine 
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Chapter 1: Introduction  
Vaccinations are vital preventative tools to help protect and significantly reduce the risk 
of various medical illnesses and disease states in the community. Pharmacists play a crucial role 
in impacting vaccination rates as certified immunizers and patient health advocates. Seen in 
multiple settings, 50%-90% of patients follow a pharmacist's advice and accept the 
recommended vaccine (Grabenstein, 1998). A 2011 study conducted by Taitel et al. showed that 
4.88% of the 1.3 million high-risk patients immunized by a pharmacist received a pneumococcal 
vaccine; this value is significantly greater than the national mark 2.90% (2011). However, one 
significant barrier to utilizing a new pharmacy service is the lack of time for pharmacists to 
implement and monitor the service (Powers & Bright, 2008).  One way to overcome this barrier 
is to utilize technicians for tasks that do not require a pharmacist's professional training. Another 
barrier specific to a new vaccination service within a pharmacy is the design of reimbursement. 
Many patients do not have health insurance plans that cover the cost of vaccinations 
administered outside of a primary care provider's office (“Addressing barriers,” 2018). This may 
limit the number of patients eligible to receive a vaccination within the pharmacy. Health 
practitioners have tried to understand the basis of vaccination hesitancy and found several 
strategies have been implemented to reduce hesitancy, such as improving the quality of vaccine 
education to patients, clearing misconceptions, decreasing wait times, improving accessibility, 
and making strong recommendations. In many community pharmacy settings, while pharmacists 
are the first-line practitioners to advocate for providing scheduled vaccinations, a deeper layer of 
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hesitancy has been observed. In many instances, within such patient-driven yet dynamic 
environments, passive pharmacist engagement and the lack of active attention in recommending 
vaccinations to patients have been observed. They have contributed to current suboptimal 
pneumococcal vaccination rates.  
Despite having clinically available and effective vaccinations to protect and prevent the 
public and susceptible patient populations, barriers exist that prevent immunization rate goal 
achievement of 90% established by Healthy People 2020. These barriers include but are not 
limited to vaccine hesitancy, lack of access, high costs, vaccine misconceptions, lack of 
education, fear of needles, and related factors (MacDonald et al., 2018). Many approaches have 
been proposed to overcome these barriers, including providing patient educational material, 
using proven communication strategies, understanding and clearing misconceptions, improving 
accessibility for vaccination, increasing provider engagement, and making strong 
recommendations. 
This study aims to report how a lean six sigma (LSS) DMAIC approach can be used to 
address specific barriers of hesitancy and vaccination rates, mainly focusing on pneumococcal 
vaccination rates. An assertive training program to educate and train community pharmacists on 
vaccine assertiveness techniques and skills focusing on increasing pneumococcal vaccination 
recommendations in adult patient populations will be described. The primary outcome is the 
positive change in pneumococcal vaccination rates before and after the intervention. 
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Pneumococcal disease, an infectious disease caused by the bacteria Streptococcus 
pneumonia (S. pneumoniae), is responsible for high incidences of morbidity and mortality each 
year in the United States and worldwide. Pneumococcal disease has the ability to cause sinusitis, 
otitis media, pneumonia, meningitis, and sepsis leading to severe and detrimental outcomes. The 
clinical presentation of pneumococcal disease typically results from bacterial colonization of the 
upper respiratory tract primarily via respiratory droplets from human to human through close 
contact. Populations at highest risk of developing pneumococcal infection include patients with 
high risk factors and health comorbidities. Patients who have any history of immunosuppression, 
chronic obstructive pulmonary disease, asplenia, and other chronic disease states are at high risk 
for developing pneumococcal infection. 
Specifically, pneumococcal vaccinations provide preventative measures in protecting 
patients of all ages and those at high risk for acquiring the disease. The two pneumococcal 
vaccinations available in the United States are the pneumococcal conjugate vaccine (PCV13) and 
pneumococcal polysaccharide vaccine (PPSV23). Current recommendations for pneumococcal 
vaccinations provided by Center for Disease Control include the PPSV23 in high-risk adults 
from 18-64 years of age and for all adults 65 and older, and the PCV13 in certain high-risk 
populations in the United States (Centers for Disease Control and Prevention [CDC], 2017). 
Studies relating to PPSV23 and PCV13 efficacy demonstrate high estimates of clinical 
effectiveness and safety for both vaccines. Overall, the PPSV23 vaccine has shown 
approximately 70% clinical effectiveness and PCV13 has shown 75% clinical effectiveness in 
preventing invasive disease caused by the bacterial serotypes (CDC, 2017).  
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Even with such high levels of efficacy in these vaccines, pneumococcal vaccination rates 
in both the U.S. and the state of Tennessee are currently below the desired benchmarks to 
improve health outcomes. A number of factors contribute to such suboptimal vaccination rates 
with vaccine hesitancy being a top priority on the list. The World Health Organization lists 
vaccine hesitancy as one of the top 10 threats to global health outcomes in 2019 (Lo & Hotez, 
2017). Vaccine hesitancy has been defined as "a delay in vaccination or a refusal to vaccinate in 
spite of vaccine availability" (Reifler et al., 2016). The majority of vaccine hesitancy research 
has been conducted in the pediatric population; however, there has been a growing interest in 
hesitancy in the adult population, a field that is currently under researched.  
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Chapter 2: Review of the Literature 
The National Health Interview Survey (NHIS) is one of the major health surveys of the 
National Center for Health Statistics, which is a principal source for gathering information on the 
health of the noninstitutionalized civilian population of the United States (2020). NHIS collects 
data on a broad range of health topics by conducting personal interviews in households with 
adults throughout the U.S. to express a sample size representative of the national population. The 
methods and design for the NHIS are continuously reevaluated and refined to assure accurate 
data representation. The 2017 NHIS data show that pneumococcal vaccination coverage among 
adults aged 19-64 years at high risk for pneumococcal disease is 24.5% and 69.0% among adults 
aged 65 years and older in the U.S. 
According to Healthy People 2020, the national objective is to increase the percentage of 
pneumococcal vaccinations in noninstitutionalized high-risk adults aged 19-64 years of age by 
90% and in noninstitutionalized adults aged 65 and older by 60%. In 2017, 74.1% of adults 
sixty-five or older received the PPSV23 vaccine in Tennessee. This number was above the 
national average of 72.4% for adults sixty-five or older (CDC, 2020).  In 2017, 34.9% of high-
risk individuals less than sixty-five years old received the pneumococcal vaccine in Tennessee.  
This number was below the national average of 36.1% of high-risk individuals less than sixty-
five years old. As the current rates in both the U.S. and the state of Tennessee are currently below 
this metric, a number of factors contribute to such suboptimal vaccination rates. These factors 
include, but are not limited to, patient hesitancy, lack of strong provider recommendation, lack of 
access due to high costs, and lack of health awareness and information. The majority of these 
factors exist primarily in the outpatient setting. The high prevalence of such factors to exist has 
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led to vaccines incompliance and is responsible for current, suboptimal pneumococcal 
vaccination rates. Researchers have tried to understand the basis of vaccination incompliance and 
found that to improve vaccine compliance, the following actions must be taken by health 
providers: provide patients educational material, use proven communication strategies, 
understand and clear misconceptions, improve accessibility for vaccination, make strong 
recommendations, and provide evidence that support the safety and effectiveness of vaccinations 
(Ventola, 2016).  
Various studies have been conducted to determine the relationship between the strength 
of the provider's recommendation for vaccinations and patient intentions to receive a vaccine, 
and these studies found a strong association correlating strength of provider recommendation to 
patient vaccinations. Many other studies also show that strong recommendation technique is 
highly critical for the protection and prevention for all populations, especially the high risk for 
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Chapter 3: Methodology 
Research question 
How can the use of Lean Six Sigma and the DMAIC process help improve pneumococcal 
vaccination rates in community pharmacy settings?  
Population 
The research includes gathering patient vaccination data from 54 community Walgreens 
pharmacies in the West Tennessee area. As part of this research, qualitative data through phone 
interviewing from community pharmacists in the selected Walgreen pharmacies were conducted. 
Study Methods  
Data collection used a multi-methods approach, including pharmacy dispensing data and in-
depth, semi-structured interviews with pharmacist key informants from the study sites. The 
design and implementation of the training program is geared towards Walgreens community 
pharmacists. Pneumococcal vaccination data were collected before and after the implementation 
of the training program followed by data analysis to determine the impact of the implementation. 
Qualitative data analysis included interviews that were conducted by trained student research 
assistants over the telephone, recorded, and subsequently transcribed verbatim by a third-party 
transcription service to evaluate the usefulness of the skills learned from the training. 
Quantitative data analysis included both descriptive and inferential statistics, including chi-
square to test the primary objective. This research will utilize a quality improvement process and 
lean six sigma methodologies to assist with the primary objective. 
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Chapter 4: LSS and The DMAIC Methodology  
LSS and DMAIC (Define, Measure, Analyze, Improve, Control) methods have been used 
in this research to focus on improving specific existing challenges in the vaccine 
recommendation process.  LSS methods have been more commonly integrated within healthcare 
in the past decade. In an early 2020 study, LSS has been used to improve access to care in 
surgical subspecialty clinics (Flanary et al., 2020).  In an area where a delay to new patient visits 
and consults challenged the care for patients, LSS was implemented to improve the timeliness of 
care for patients and reduce its variation by improving clinic processes and scheduling. 
LSS has been a model used in other aspects of healthcare as well such as pharmacy. 
While pharmacy is a demanding, patient- driven field, many of its issues lie within patient 
experiences and inefficiencies that ultimately lead to patient dissatisfaction. Recently in a 2018 
study, LSS was incorporated into pharmacy practice to reduce pharmacy wait time. LSS methods 
in this study were used to identify potential problems associated with increased wait times and 
found that implementations such as automated queuing technology, pharmacy devices for quick 
and accurate filling and dispensing, and computer simulation modeling for smooth workflow 
were solutions to the issue (Alam, 2018). LSS methodologies have been utilized in several 
settings to reduce patient wait time, attract new customers, decrease workload and improve the 
overall efficiency within the organization. 
DMAIC is an aspect within LSS that includes defining a problem, quantifying the 
problem, analyzing the cause of the problem, implementing a feasible solution, and maintaining 
the solution. The integration of DMAIC in this research provides a well-guided approach to help 
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improve the efficiency and performance within the process of vaccination recommendation and 
assertiveness. The implementation of the DMAIC process has been utilized to address the 
standards and approach currently used in the pneumococcal vaccination recommendation process 
at participating Walgreens pharmacies. 
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Chapter 5: DMAIC Case Study 
 
Define 
The problem of interest is pneumococcal vaccine rates below specification in community 
pharmacies. Specifications were based in Healthy People 2020, rather than traditional voice of 
consumer (VoC) analyses given the uniqueness of the product of interest (i.e. a vaccine).  A 
high-level map of vaccine recommendation processes, as shown in Figure 1, was conducted to 
determine the key factors affecting vaccine recommendation. With Walgreens divisional 
leadership, the objective to increase pneumococcal vaccination rates across Tennessee by 20% 







Base line (e.g. "current state") data from the dispensing history for pneumococcal 
vaccinations administered was gathered from each pharmacy and was compared across the 
pharmacy division.  Key informant interviews were conducted to provide context on processes in 
community pharmacy workflow.  
Figure 1
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Baseline data from historical pharmacy dispensing data was used to understand correlations 
between staffing and hours of operations and vaccination rates, but no significant correlations 
were identified after conducting a regression analysis.  Content analysis of interview 
transcriptions highlighted vaccination hesitancy and related barriers present during pharmacist 
recommendations. A cause-and-effect matrix along with a failure modes and effects analysis 
(FMEA) were conducted to determine the potential root cause and determinant to the 
overarching issue and are shown in Figures 2 and 3, respectively. As a result, the vaccine 
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To improve the recommendation communication technique, implementing a training 
program has been decided to potentially be the most feasible and sound way to educate and 
improve vaccine rates in pharmacies. The intent of the training program is to focus on educating 
and training pharmacists on vaccine assertiveness technique and will be implemented within the 
community pharmacies study sites. The training was directed towards study site pharmacists 
representing and consisted of both online and live training sessions. The training program 
centered on the concept of "presumptive" vaccine recommendations motivational interviewing 
and the transtheoretical model to guide pharmacists through behavior change toward vaccine 
recommendation acceptance. The live sessions were led by faculty facilitators and included 
Figure 3 
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practice of key verbiage and mock sessions to practice improving the communication of vaccine 
recommendations.  
Results of the Implementation 
The results of the study were gathered through a variety of statistical tests to test the 
effectiveness of the training program. The Chi Square test, represented in Figure 4, was used for 
unpaired, bivariate data which represents the dataset of pneumococcal vaccines pre- 
implementation and post implementation. Thereafter, a capability analysis test was conducted to 
evaluate the process capability, Cp, Cpk, and p-value. A total of 54 pharmacies completed the 
experiment, including 25 intervention sites. Of these, 8 increased by 20%. Of the 29 control sites 
that did not receive training, 4 increased by the specification of 20%. Year-over-year comparison 
of mean pneumococcal vaccination rates showed no significant difference (p<0.05). The new 
processes capability analysis was run as a one-sided analysis with a goal and LSL of 20% to 
compare the 2018 vs 2019 vaccination rates, as shown in Figure 5. The analysis revealed 70.49% 
of the stores fell below the LSL and did not achieve the goal of increasing vaccinations by 20%, 
as displayed in the process capability report in Figure 6. To show the results in a simpler format, 
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After conducting the training program with pharmacists, trends in pneumococcal 
vaccination rates over the course of a year at each pharmacy will be monitored. This will help 
evaluate the skills and assertive techniques that were adapted and integrated by each pharmacist 
at each Walgreens pharmacy. At the end of the training program, pharmacists will be provided 
"Reference Guides" of the vaccine recommendation process, as represented in Figure 7, to attach 
to their computer monitors at their respective sites to remind and ensure each eligible vaccine 
recommendation is strong and assertive. Adherence to these guides will be a fidelity outcome 
and will help to evaluate the extent to which each pharmacy adapted to the lessons learned from 
the training. Finally, follow up interviews will be performed with pharmacists post- 
implementation to discuss the strengths and weaknesses of the training and evaluate the 
usefulness of the skills learned from the training sessions. 
Figure 7 
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Chapter 6: Discussion  
The primary focus of training program was to improve the quality of pneumococcal 
vaccine recommendations pharmacists provide in the community setting to increase the overall 
rates of vaccinations and optimize health outcomes. Research has suggested that the influence of 
quality recommendations has a significant impact on vaccine behaviors and vaccine initiation. In 
a prior research study examining the correlation between the quality of a vaccine 
recommendation to vaccine initiation, researchers found that receiving a high-quality 
recommendation versus no recommendation was associated with over nine times the odds of 
having received the vaccination and four times the odd compared to a low-quality 
recommendation (Gilkey et al., 2016). The study also found that higher recommendation quality 
was associated with less vaccination refusal and delay. It is quite evident that higher quality 
recommendations significantly influenced the decision making of receiving the vaccination and 
led to higher overall initiation rates.  
Limitations and Insights 
While the outcomes of the training program did not result as expected a discussion to 
help identify various factors that may have contributed to the variable outcomes of the training 
program can help understand and address the shortcomings of this research. To understand both 
the factors of success and the potential barriers to implementing and sustaining the 
implementation of the training program, we used the Consolidated Framework for 
Implementation Research (CFIR) to help evaluate various factors in a systematic approach. We 
examined each domain of the CFIR construct such as intervention characteristics, outer setting, 
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inner setting, characteristics of individuals, and process of implementation to consider issues that 
both facilitated and hindered implementation.  
When considering intervention characteristics, several relative advantages of the 
implementation were noted. The training program intended to equip pharmacists with stronger 
skills in their communication and assertive techniques to improve pneumococcal vaccine rates 
and improve overall patient health. The training program was adaptable to all community 
pharmacies where there is convenience in providing vaccinations and feasibility to implement in 
routine practice. 
 Regarding outer setting, patient resources were considered in terms of if there was a 
willingness for patients to engage in active discussion during a vaccine recommendation. 
External policies such as insurance coverage can influence patients' decision to receive 
vaccinations. Another important consideration is the pre-administration processing time of a 
vaccination which can influence and defer patients from receiving vaccinations at the pharmacy 
In terms of inner setting, understanding the culture, implementation climate, and 
readiness for implementation were critical. Community pharmacies, in general, are sometimes 
perceived as environments of high tension where pharmacists are challenged with multiple 
initiatives and benchmarks that are considered more important than others. And as a common 
result, more efforts are typically directed to initiatives that are incentivized versus those that are 
not. Time and workload were other barriers commonly seen that may have impacted the climate 
of learning new vaccine recommendation techniques and integrating within practice. 
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In terms of characteristics of individuals, it is valuable to consider the knowledge and 
beliefs about the intervention, and vaccinations in general. The intended purpose of the training 
program was to improve pharmacist recommendation technique, expand patient education, and 
help dissolve several hesitancy factors including culture and misconceptions. While acquiring 
new knowledge and further solidifying important strategies, attitudes and perception play an 
important role in a new implementation. That is why we may consider another barrier to 
successful implementation: the resistance to change in routine and resolute perceptions.  
Lastly, we may reassess the process of implementation: the planning and execution of the 
training program. Perhaps another reason for unsuccessful improvement was simply a weak 
implementation of the program or weak integration of techniques within the pharmacies after 
implementation. Perhaps, our strategies may have not been strong enough to adapt firmly and 
integrate within the participating pharmacies. As a means of reflecting and evaluating the 
effectiveness of the training program, we conducted interviews with pharmacists that participated 
in the training post implementation. From the interviews, we acquired qualitative data and gained 
perspective on aspects of the program that were integrated successfully as well as measures for 
quality improvement. Future studies may focus on the strategy of implementation and 
improvement to better correlate an assertive training program for pharmacists to improve 
vaccination rates in the community setting. 
Conclusion 
Though quantitative data did not suggest a strong enough correlation to determine the 
impact of the training program to the overall increase in pneumococcal vaccination rates, this 
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research provides future direction on how community pharmacists can better facilitate vaccine 
recommendations and be key players in improving overall vaccination rates to better patient 
outcomes. In regard to the data analysis, we found settings where the training program was 
beneficial and others where they were not. Considering several influential factors that may be 
outside of the study's control, it is difficult to determine whether or not the training program 
positively or negatively impacted pneumococcal vaccination rates in community pharmacies. 
Perhaps, the lessons learned from this research study can provide future researchers and 
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